Nexentis Technologies Inc. (NXTS) stock

NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30

$2.21+0.20 (+9.95%)

Close on Nov 13, 2026Market cap $3.21MP/E –Yield –

Nexentis Technologies statistics

55 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $3.21M; $272.32M
Enterprise Value: -$5.58M; $146.23M
PB Ratio: 1.69; 2.00

Share statisticsIndustry

Shares Outstanding: 1M; 58M
Shares Change (QoQ): 99.0%; 0.50%
Shares Held by Institutions: 4.36%; 56.4%

Short sellingIndustry

Short Interest: 63,636; –
Short Interest Change: 3.85%; -0.80%
Short % of Shares Outstanding: 4.38%; 6.30%
Days to Cover: 1.00; 5.15

Stock price statisticsIndustry

52-Week High: $119.00; –
52-Week Low: $1.93; –
20-Day Moving Average: $2.71; –
50-Day Moving Average: $4.97; –
200-Day Moving Average: $18.02; –
Average True Range (14): $0.48; –
Price Change (1 Week): -13.3%; -1.15%
Price Change (1 Month): -35.0%; -4.87%
Price Change (3 Months): -77.2%; -21.0%
Price Change (6 Months): -90.1%; -20.6%
Price Change (YTD): -96.2%; -23.6%
Price Change (1 Year): -98.0%; -22.4%
Price Change (3 Years): -99.9%; -29.5%
Price Change (5 Years): -100.0%; -77.9%
Average Volume (10 Days): 39,004; –
Average Volume (20 Days): 55,982; –
Average Volume (90 Days): 63,753; –
Relative Volume: 0.12; 0.70
Relative Strength Index (14): 29.4; 43.4
Volatility (1 Year): 203.7%; 80.1%
Beta (5 Years): 0.30; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -417.9%; -49.9%
Return on Assets (ROA): -121.2%; -40.6%
Return on Capital Employed (ROCE): -68.4%; -37.9%

Financial positionIndustry

Current Ratio: 3.72; 3.30
Quick Ratio: 3.18; 2.39
Debt / Equity: 0.11; 0.49

EfficiencyIndustry

Profits Per Employee: -$2.29M; -$689.41K
Employee Count: 7; 74
WACC: 7.48%; 10.2%

Income statement (TTM)Industry

Operating Income: -$10.88M; -$21.37M
Net Income: -$16.03M; -$22.35M
EBITDA: -$10.62M; -$17.21M

Balance sheetIndustry

Cash & Short-Term Investments: $8.88M; $68.68M
Total Debt: $215.00K; $116.91M
Net Cash (Debt): $8.67M; $17.76M
Net Cash Per Share: $5.96; $0.80
Equity (Book Value): $1.91M; $53.89M
Book Value Per Share: $1.31; $1.50
Tangible Book Value: -$2.32M; $27.13M
Working Capital: $7.60M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$4.43M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -499.0%; -21.8%

Scores and fair valueIndustry

Altman Z-Score: -5.53; 0.23
Piotroski F-Score: 4; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	NXTS	S&P 500	Difference	NXTS per year	S&P 500 per year
1 month	-37.2%	-3.0%	−34.2 pts
3 months	-77.3%	-2.8%	−74.6 pts
Year to date	-96.2%	+11.5%	−107.7 pts
1 year	-98.0%	+13.5%	−111.5 pts
3 years	-99.9%	+77.7%	−177.6 pts	-90.9%	+21.1%
5 years	-100.0%	+72.6%	−172.6 pts	-87.2%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M NXTS shares were sold short on Oct 30, 2026, up 3.9% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 44.1% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	63,636	+3.9%	331,232	1.0
Oct 15, 2026	61,274	+62.4%	1,706,331	1.0
Sep 30, 2026	37,720	-4.4%	59,267	1.0
Sep 15, 2026	39,461	-24.8%	17,534	2.3
Aug 31, 2026	52,477	-16.3%	30,950	1.7
Aug 14, 2026	62,682	+1.2%	54,536	1.1
Jul 31, 2026	61,966	+122.8%	96,447	1.0
Jul 15, 2026	27,813	-71.4%	104,598	1.0
Jun 30, 2026	97,136	+717.8%	7,559,275	1.0
Jun 15, 2026	11,877	-52.7%	15,265	1.0
May 29, 2026	25,088	+10.2%	69,351	1.0
May 15, 2026	22,760	-1.1%	38,341	1.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?